Synthesis, electrochemical and biological studies on polyfunctionalized 4-ferrocenyl-4H-pyran and 4-ferrocenyl-1,4-dihydropyridine derivatives

The first synthesis of polyfunctionalized 4-ferrocenyl-4H-pyran and 4-ferrocenyl-1,4-dihydropyridine derivatives, as well as some of their relevant properties, including an electrochemical study and some aspects of their biological profile have been described.     

Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

Herein we have reviewed our recent developments for the identification of new tacrine analogues for Alzheimer's disease (AD) therapy. Tacrine, the first cholinesterase inhibitor approved for AD treatment, did not stop the progression of AD, producing only some cognitive improvements, but exhibited secondary effects mainly due to its hepatotoxicity. Thus, the drug was withdrawn from the clinics administration. Since then, many publications have described non‐hepatotoxic tacrines, and in addition, important efforts have been made to design multitarget tacrines by combining their cholinesterase inhibition profile with the modulation of other biological targets involved in AD.     

Synthesis and X-ray structures of new cycloalka[e]pyrano[2,3-b]pyridine derivatives: novel tacrine analogues

A new series of tacrine (9-amino-1,2,3,4-tetrahydroacridine) analogues consisting of a cycloalka[e]pyrano[2,3-b]pyridine linked to a quinolyl ring has been synthesized. These compounds were prepared from the appropriately substituted pyran derivative via a Friedländer reaction with selected cycloalkanones in high yields. Single crystal X-ray structures are reported for four compounds.     

Rapid access to novel 2-alkylthiopyrimidine derivatives and attempt of their Tacrine analogs synthesis

A variety of novel 2-alkylthiopyrimidines were synthesized through simple condensation of arylidenemalononitriles with different 2-alkylthiouronium halide derivatives catalyzed by anhydrous potassium carbonate (K₂CO₃). The reactions have been carried out under mild conditions in i-PrOH, and the products were obtained in moderate to good yields with a simple work-up method. Subsequently, some examples of these compounds have been converted into Tacrine analogs by applying the Friedländer reaction.     

Development of Neuropeptide Y and Cell-Penetrating Peptide MAP Adsorbed onto Lipid Nanoparticle Surface

Functionalization of nanoparticles surfaces have been widely used to improve diagnostic and therapeutic biological outcome. Several methods can be applied to modify nanoparticle surface; however, in this article we focus toward a simple and less time-consuming method. We applied an adsorption method on already formulated nanostructured lipid carriers (NLC) to functionalize these nanoparticles with three distinct peptides sequences. We selected a cell-penetrating peptide (CPP), a lysine modified model amphipathic peptide (Lys(N₃)-MAP), CPP/drug complex, and the neuropeptide Y. The aim of this work is to evaluate the effect of several parameters such as peptide concentration, different types of NLC, different types of peptides, and incubation medium on the physicochemical proprieties of NLC and determine if adsorption occurs. The preliminary results from zeta potential analysis indicate some evidence that this method was successful in adsorbing three types of peptides onto NLC. Several non-covalent interactions appear to be involved in peptide adsorption with the possibility of three adsorption peptide hypothesis that may occur with NLC in solution. Moreover, and for the first time, in silico docking analysis demonstrated strong interaction between CPP MAP and NPY Y1 receptor with high score values when compared to standard antagonist and NPY.     

Synthesis of 2H-3,1-pyrazolo[3,4-e]oxazines via a new conversion of Friedlander reaction

2H-3,1-Pyrazolo[3,4-e]oxazines (5a-c) and tacrine analogies (6a-c) were designed and prepared using 5-amino-4-cyanopyr-azole (7) and cycloketones (2a-c) as reactants. The study demonstrated that the new conversion existed in the Friedlander reaction of o-aminocyanopyrazole with cycloketones.     

Synthesis of substituted [1,3]thiazolo[4,5-b]pyridines and [1,3]thiazolo[4,5-d][1,2,3]triazines

In this work, we described an easy preparation of substituted 4-amino-5-cyano-1,3-thiazoles. These compounds have been used as starting materials to obtain two classes of compounds. New substituted [1,3]thiazolo[4,5-e]pyridines were synthesized in one step via Friedländer reaction. Diazotation of 4-amino-5-cyano-1,3-thiazoles afforded 4-chloro[1,3]thiazolo[4,5-d][1,2,3]triazines in one step. The later was substituted by a secondary amine to obtain substituted 4-amino[1,3]thiazolo[4,5-d][1,2,3]triazines.     

p53突变体Y220C小分子稳定剂的虚拟筛选

为了获得p53突变体的稳定剂,依次利用利宾斯基五原则,通过2次分子对接和全原子分子动力学(MD)模拟从Drug Bank 4.0数据库中筛选获得了潜在的稳定剂他克林.利用MD模拟进一步验证他克林和目标蛋白质之间的亲和作用.结果表明,他克林能够紧密结合到Y220C突变所形成的疏水空腔之中;他克林和目标蛋白质之间的主要作用力为疏水和静电相互作用,其中疏水相互作用占主导地位.此外,他克林分别与目标蛋白质的残基Leu145,Val147和Asp228形成3个氢键.基于MD模拟轨迹分析了他克林与p53CY220C的结合过程.由硫黄素T荧光光谱进一步证明他克林能够提高p53C-Y220C突变体的稳定性.